Anna Eshoo actually said...

"the rising drug costs and need for greater transparency in the whole chain."

"To the manufacturers, again: Are there any other fees or monies that are associated with manufacturers and PBMs that I have missed?"

"I still don't quite get it but I want to move on to my next question."

"We're going to follow the money. We're examining the system from beginning to end because in order to fix it, we must understand it, and then, we're going to act."